Escalating Regulatory Scrutiny And Patent Risks Will Constrain Margins
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 15 Analysts
Published
16 Jun 25
Updated
20 Aug 25
AnalystLowTarget's Fair Value
DKK 1,000.00
57.0% overvalued intrinsic discount20 Aug
DKK 1,570.00
1Y
-13.9%7D
4.8%